Puma Biotechnology, Inc. (PBYI) Reports Q3 Loss of $1.29

Puma Biotechnology, Inc. (: PBYI) reported Q3 EPS of ($1.29), versus ($0.09) reported last year. Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Puma Biotechnology, Inc. (PBYI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Cooper Companies (COO) Reiterated at Buy by Stifel After Earnings Call
• Sharon AI secures six-year compute deal with NVIDIA for Australia deployment